Effectiveness of Corticosteroid-Sparing Topical Treatments for Vernal Keratoconjunctivitis in Children: A Report by the American Academy of Ophthalmology

Glaucoma and Ocular Pressure

Visual Electrophysiology for the Diagnosis of Glaucoma: A Report by the American Academy of Ophthalmology

Ophthalmology

Ou Y, Chopra V, Rosdahl JA, Richter GM, Knight OJ, Solá-Del Valle D, Takusagawa HL, Kim SJ, WuDunn D

doi: 10.1016/j.ophtha.2026.04.014

Retinal Diseases

Geographic Distribution of Access to Diabetic Retinopathy Care in the United States: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Analysis

Ophthalmology

Singh Parmar UP, Fujita A, Lokhande A, Palia R, Yang E, Lorch A, Singh RP, Gong D, Zebardast N, IRIS® Registry Analytic Center Consortium

doi: 10.1016/j.ophtha.2026.07.006

Macular Diseases

Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network Report

Ophthalmol Sci

Spindler J, Artemiev D, Pfister IB, Schild C, Tillmann A, Heck K, Gabathuler F, Ruscitti L, Spitznagel T, Kitsos-Kalyvianakis K, Munk MR, Hatz K, Zweifel SA, Grimaldi G, Somfai GM, Ambresin A, Weinberger A, Eandi CM, Feltgen N, Kitay A, Ebneter A, Garweg JG

doi: 10.1016/j.xops.2026.101087

Glaucoma and Ocular Pressure

Adverse Events and Intraocular Pressure-Lowering Effect of Topical 0.5% Apraclonidine in Childhood Glaucoma: A Retrospective Single-Center Study

Ophthalmol Glaucoma

Elhusseiny AM, Macaron MM, Hassan AK, Chang TC

doi: 10.1016/j.ogla.2026.03.002

Further Publications

Ocular Risks of Topical Atropine Prescriptions Among Taiwanese Children

JAMA Ophthalmol

Liu YL, Tsai JY, Chiu KY, Tsai IJ, Morgan IG, Tsai TH, Wang IJ

doi: 10.1001/jamaophthalmol.2025.3090

Macular Diseases

One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report

Ophthalmol Ther

Grimaldi G, Bartolomeo N, Garweg JG, Pfister IB, Schild C, Peyla A, Tillmann A, De Oliveira Figueiredo EC, Spitznagel T, Kitay AM, Gabathuler F, Zweifel S, Kurz-Levin MM, Ebneter A, Somfai GM, Eandi CM, Munk MR, Ambresin A, Menghini M

doi: 10.1007/s40123-025-01305-w

Macular DiseasesRetinal Diseases

One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report

Ophthalmol Ther

Tillmann A, Stillenmunkes R, Garweg JG, Cattaneo J, Bartolomeo N, Grimaldi G, Spitznagel T, De Oliveira Figueiredo EC, Ambresin A, Menghini M, Somfai GM, Zweifel S, Fröhlich J, Artemiev D, Ebneter A, Hatz K, Weinberger A, Pfister IB, Schild C, Eandi C, Munk MR, Swiss Retina Research Network

doi: 10.1007/s40123-025-01252-6

Macular Diseases

The long-term impact of neovascular age-related macular degeneration undergoing routine treatment in first and second eyes on vision-related quality-of-life: FASBAT Report 3

Acta Ophthalmol

Airody A, Hanson RLW, Bunola-Hadfield I, Sivaprasad S, Morland AB, Chakravarthy U, Gale RP, FASBAT study group

doi: 10.1111/aos.70150

Retinal Diseases

Special Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2026 Revision)

Ophthalmology

Marmor MF, Ahn SJ, Ehlers JP, Melles RB, Mieler WF, Sarraf D, Yusuf IH, American Academy of Ophthalmology

doi: 10.1016/j.ophtha.2025.11.001

Related content

Visual Electrophysiology for the Diagnosis of Glaucoma: A Report by the American Academy of Ophthalmology

Geographic Distribution of Access to Diabetic Retinopathy Care in the United States: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Analysis

Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network Report

Adverse Events and Intraocular Pressure-Lowering Effect of Topical 0.5% Apraclonidine in Childhood Glaucoma: A Retrospective Single-Center Study

Ocular Risks of Topical Atropine Prescriptions Among Taiwanese Children

One-Year Real-World Outcomes of Aflibercept 8 mg in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report

One-Year Outcomes of Faricimab in Treatment-Naïve Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report

The long-term impact of neovascular age-related macular degeneration undergoing routine treatment in first and second eyes on vision-related quality-of-life: FASBAT Report 3

Special Report: Recommendations on Screening for Hydroxychloroquine Retinopathy (2026 Revision)